International Journal of Dermatology

Hyperhidrosis
pp. 561-567(17)
Authors: Leung A.K.C.; Mbbs .; Frcplond .; Chan P.Y.H.; Choi M.C.K.

A clinical approach to leukoderma
pp. 568-572(5)
Author: Bolognia J.L.

The microbiology of infected and noninfected leg ulcers
pp. 573-578(6)
Authors: Bowler P.G.; Davies B.J.

Microbiology of infected pustular psoriasis lesions
pp. 579-581(3)
Authors: Brook I.; Frazier E.H.; Yeager J.K.

Characteristics of bacterial skin infections in children compared to adults at a tertiary dermatologic center
pp. 582-586(5)
Authors: Sugeng M.W.; Ang P.; Tan H.H.; Goh C.L.; Centre F.T.N.S.; Singapore .

Cutaneous leishmaniasis in Yemen
pp. 587-590(4)
Authors: Khatri M.L.; Haider N.

Onychomycosis in Lahore, Pakistan
pp. 591-595(5)
Authors: Bokhari M.A.; Mcps .; Hussain I.; Fcps .; Jahangir M.; Mcps .; Haroon T.S.; Fcps .; Aman S.; Mcps .; Khurshid K.; Mcps .; Fcps .

Generalized pustular eruptions associated with oral terbinafine
pp. 596-600(5)
Authors: Bennett M.L.; Jorizzo J.L.; White W.L.

Fluconazole vs. Itraconazole in the treatment of tinea versicolor
pp. 601-603(3)
Authors: Montero-Gei F.; Robles M.E.; Suchil P.

A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone
pp. 604-606(3)
Authors: Lebwohl M.; group T.M.F.S.

Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis
pp. 607-609(3)
Authors: Mujtaba G.; Mbbs .; Fcps .; Khalid M.; Mbbs .; Fcps .

A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran
pp. 610-612(3)
Authors: Zerehsaz F.; Salmanpour R.; Handjani F.; Ardehali S.; Panjehshahin M.R.; Tabei S.Z.; Tabatabaee H.R.; Ms .

Reassessment of the suction blister model of wound healing: introduction of a new higher pressure device
pp. 613-617(5)
Authors: Alexis A.F.; Wilson D.C.; Todhunter J.A.; Stiller M.J.

Perianal candidosis—a comparative study with mupirocin and nystatin
pp. 618-622(5)
Authors: de Wet P.M.; Rode H.; van Dyk A.; Millar A.J.W.

Maggot therapy for the treatment of intractable wounds
pp. 623-627(5)
Authors: Mumcuoglu K.Y.; Ingber A.; Gilead L.; Stessman J.; Friedmann R.; Schulman H.; Bichucher H.

Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy
pp. 628-632(5)
Authors: Franz T.J.; Parsell D.A.; Halualani R.M.; Hannigan J.F.; Kalbach J.P.; Ma .; Harkonen W.S.

Fever therapy for general paresis
pp. 633-637(5)
Author: Albert M.R.

Correspondence O tempora o mores: the cost of managing institutional outbreaks of scabies
pp. 638-640(3)
Authors: Papini M.; Maccheroni R.; Bruni P.L.